Publicaciones en colaboración con investigadores/as de Hospital Universitario Puerta de Hierro (10)

2024

  1. Blood tumor mutational burden and response to pembrolizumab plus chemotherapy in non–small cell lung cancer: KEYNOTE-782

    Lung Cancer, Vol. 190

  2. Spatially Preserved Multi-Region Transcriptomic Subtyping and Biomarkers of Chemoimmunotherapy Outcome in Extensive-Stage Small Cell Lung Cancer

    Clinical Cancer Research, Vol. 30, Núm. 14, pp. 3036-3049

2022

  1. A phase II randomised trial of abiraterone acetate plus prednisone in combination with docetaxel or docetaxel plus prednisone after disease progression to abiraterone acetate plus prednisone in patients with metastatic castration-resistant prostate cancer: The ABIDO-SOGUG trial

    European Journal of Cancer, Vol. 175, pp. 110-119

2020

  1. ASTRIS, a large real-world study to evaluate the efficacy of osimertinib in epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer patients: Clinical characteristics and genotyping methods in a Spanish cohort

    Revista Espanola de Patologia, Vol. 53, Núm. 3, pp. 140-148

2013

  1. Dolor como factor predictor de depresión en el paciente oncológico: estudio de casos y controles. Estudio D-PRESS

    Revista de la Sociedad Espanola del Dolor, Vol. 20, Núm. 3, pp. 113-121

2012

  1. Análisis económico de oxicodona LP/naloxona LP en el manejo del dolor intenso y el estrenimiento asociado al tratamiento con opioides en España

    Pharmacoeconomics - Spanish Research Articles, Vol. 9, Núm. 1, pp. 21-32

2009

  1. Inhaled IL-2 induces systemic immunomodulation in patients with renal cell carcinoma and lung metastasis

    Cancer Immunology, Immunotherapy, Vol. 58, Núm. 2, pp. 235-245

  2. Management of platinum-resistant ovarian cancer with the combination of pemetrexed and gemcitabine

    Clinical and Translational Oncology, Vol. 11, Núm. 1, pp. 35-40

2008

  1. Circulating tumor cells in breast cancer: Methodology and clinical repercussions

    Clinical and Translational Oncology, Vol. 10, Núm. 7, pp. 399-406

2007

  1. Retrospective review in patients with pulmonary metastases of renal cell carcinoma receiving inhaled recombinant interleukin-2

    Anti-Cancer Drugs, Vol. 18, Núm. 3, pp. 291-296